,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-01-19 00:38:00,"For the details of GEORGIA BENNICAS DBA BENNICAS & ASSOCIATES's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=GEORGIA+BENNICAS+DBA+BENNICAS+%26+ASSOCIATES

These are the top 5 holdings of GEORGIA BENNICAS DBA BENNICAS & ASSOCIATES
• Procter & Gamble Co ( PG ) - 168,997 shares, 13.68% of the total portfolio.",0.01684122532606125,0.008845381438732147,0.9743133783340454,neutral,0.007995843887329102
1,2017-01-19 00:38:00,"Shares reduced by 1.08%
• Microsoft Corp ( MSFT ) - 53,714 shares, 3.21% of the total portfolio.",0.01854894310235977,0.9687142372131348,0.012736811302602291,negative,-0.9501652717590332
2,2017-01-19 00:38:00,"Shares reduced by 1.62%
• Newmont Mining Corp ( NEM ) - 88,368 shares, 2.9% of the total portfolio.",0.017873942852020264,0.9692413806915283,0.012884626165032387,negative,-0.9513674378395081
3,2017-01-19 00:38:00,"Shares added by 4.37%
• Intel Corp ( INTC ) - 79,100 shares, 2.76% of the total portfolio.",0.05584082752466202,0.12445063889026642,0.819708526134491,neutral,-0.0686098113656044
4,2017-01-19 00:38:00,"Shares reduced by 0.63%
• Clorox Co ( CLX ) - 23,757 shares, 2.74% of the total portfolio.",0.01850685104727745,0.9685852527618408,0.012907826341688633,negative,-0.9500784277915955
5,2017-01-19 00:38:00,"Shares reduced by 0.21%

Georgia Bennicas Dba Bennicas & Associates initiated holdings in Kellogg Co.",0.03533123433589935,0.7397637367248535,0.22490505874156952,negative,-0.704432487487793
6,2017-01-19 00:38:00,"The purchase prices were between $70.96 and $77.25, with an estimated average price of $74.06.",0.023362789303064346,0.010800090618431568,0.9658370614051819,neutral,0.012562698684632778
7,2017-01-19 00:38:00,The stock is now traded at around $71.81.,0.04131798446178436,0.006073133088648319,0.9526088833808899,neutral,0.03524485230445862
8,2017-01-19 00:38:00,The impact to the portfolio due to this purchase was 1.81%.,0.021085968241095543,0.24167513847351074,0.737238883972168,neutral,-0.22058917582035065
9,2017-01-19 00:38:00,"The holdings were 25,500 shares as of 2016-12-31.",0.013506779447197914,0.007176064886152744,0.9793171286582947,neutral,0.00633071456104517
10,2017-01-19 00:38:00,Georgia Bennicas Dba Bennicas & Associates initiated holdings in Gilead Sciences Inc.,0.038917191326618195,0.00819923635572195,0.9528836011886597,neutral,0.03071795403957367
11,2017-01-19 00:38:00,"The purchase prices were between $71.61 and $78.47, with an estimated average price of $74.33.",0.021952660754323006,0.012114454060792923,0.9659328460693359,neutral,0.009838206693530083
12,2017-01-19 00:38:00,The stock is now traded at around $71.55.,0.04006684198975563,0.0059657287783920765,0.9539674520492554,neutral,0.03410111367702484
13,2017-01-19 00:38:00,The impact to the portfolio due to this purchase was 1.57%.,0.02054581418633461,0.2345215529203415,0.7449325919151306,neutral,-0.21397574245929718
14,2017-01-19 00:38:00,"The holdings were 22,700 shares as of 2016-12-31.",0.014282596297562122,0.007131749298423529,0.9785856008529663,neutral,0.007150846999138594
15,2017-01-19 00:38:00,Georgia Bennicas Dba Bennicas & Associates initiated holdings in Regeneron Pharmaceuticals Inc.,0.0587037056684494,0.007865851745009422,0.9334304928779602,neutral,0.05083785206079483
16,2017-01-19 00:38:00,"The purchase prices were between $336.01 and $444.52, with an estimated average price of $380.27.",0.0177655890583992,0.01620863936841488,0.966025710105896,neutral,0.0015569496899843216
17,2017-01-19 00:38:00,The stock is now traded at around $363.08.,0.03662257269024849,0.00613443972542882,0.9572429656982422,neutral,0.030488133430480957
18,2017-01-19 00:38:00,The impact to the portfolio due to this purchase was 0.69%.,0.021973730996251106,0.35873061418533325,0.6192956566810608,neutral,-0.3367568850517273
19,2017-01-19 00:38:00,"The holdings were 1,950 shares as of 2016-12-31.",0.013476870022714138,0.007253279443830252,0.9792698621749878,neutral,0.006223590578883886
20,2017-01-19 00:38:00,Georgia Bennicas Dba Bennicas & Associates initiated holdings in Vestas Wind Systems A/S.,0.08245499432086945,0.005912249907851219,0.911632776260376,neutral,0.07654274255037308
21,2017-01-19 00:38:00,"The purchase prices were between $18.57 and $28.1, with an estimated average price of $23.12.",0.018135039135813713,0.012433660216629505,0.9694312810897827,neutral,0.005701378919184208
22,2017-01-19 00:38:00,The stock is now traded at around $22.38.,0.035906899720430374,0.006015711929649115,0.9580773115158081,neutral,0.029891187325119972
23,2017-01-19 00:38:00,The impact to the portfolio due to this purchase was 0.51%.,0.021205438300967216,0.36480000615119934,0.6139945387840271,neutral,-0.34359458088874817
24,2017-01-19 00:38:00,"The holdings were 24,500 shares as of 2016-12-31.",0.013532514683902264,0.00736338971182704,0.9791041612625122,neutral,0.006169124972075224
25,2017-01-19 00:38:00,Georgia Bennicas Dba Bennicas & Associates initiated holdings in Omega Healthcare Investors Inc.,0.04972086846828461,0.007973169907927513,0.9423059225082397,neutral,0.041747696697711945
26,2017-01-19 00:38:00,"The purchase prices were between $28.31 and $35.04, with an estimated average price of $30.87.",0.01735643483698368,0.012014004401862621,0.9706295728683472,neutral,0.005342430435121059
27,2017-01-19 00:38:00,The stock is now traded at around $32.11.,0.03759382292628288,0.006015054415911436,0.9563911557197571,neutral,0.03157876804471016
28,2017-01-19 00:38:00,The impact to the portfolio due to this purchase was 0.23%.,0.023066146299242973,0.3699154257774353,0.6070184111595154,neutral,-0.3468492925167084
29,2017-01-19 00:38:00,"The holdings were 7,800 shares as of 2016-12-31.",0.014779389835894108,0.006892700679600239,0.9783278703689575,neutral,0.007886689156293869
30,2017-01-19 00:38:00,Georgia Bennicas Dba Bennicas & Associates sold out the holdings in Healthcare Realty Trust Inc.,0.017648333683609962,0.08712339401245117,0.8952283263206482,neutral,-0.06947506219148636
31,2017-01-19 00:38:00,"The sale prices were between $27.74 and $33.61, with an estimated average price of $30.48.",0.01646476611495018,0.013613162562251091,0.9699221253395081,neutral,0.002851603552699089
32,2017-01-19 00:38:00,Georgia Bennicas Dba Bennicas & Associates sold out the holdings in Quality Care Properties Inc.,0.01849709078669548,0.11056865751743317,0.870934247970581,neutral,-0.09207156300544739
33,2017-01-19 00:38:00,"The sale prices were between $12.48 and $19, with an estimated average price of $15.23.",0.0155606959015131,0.012175381183624268,0.9722639918327332,neutral,0.003385314717888832
34,2017-01-19 00:38:00,Georgia Bennicas Dba Bennicas & Associates reduced to the holdings in Engie SA by 27.66%.,0.019406717270612717,0.9567571878433228,0.02383614331483841,negative,-0.9373504519462585
35,2017-01-19 00:38:00,"The sale prices were between $11.87 and $15.37, with an estimated average price of $13.39.",0.016448359936475754,0.014253132976591587,0.9692985415458679,neutral,0.0021952269598841667
36,2017-01-19 00:38:00,The stock is now traded at around $12.51.,0.03761215880513191,0.005663220304995775,0.9567245841026306,neutral,0.031948938965797424
37,2017-01-19 00:38:00,The impact to the portfolio due to this sale was -0.22%.,0.028206024318933487,0.243032768368721,0.7287612557411194,neutral,-0.21482674777507782
38,2017-01-19 00:38:00,"Georgia Bennicas Dba Bennicas & Associates still held 38,700 shares as of 2016-12-31.",0.015234173275530338,0.012711693532764912,0.9720541834831238,neutral,0.0025224797427654266
39,2017-01-19 00:38:00,• Warning!,0.191152885556221,0.27946969866752625,0.5293774604797363,neutral,-0.08831681311130524
40,2017-01-19 00:38:00,GuruFocus has detected 7 Warning Signs with K. Click here to check it out.,0.05419882386922836,0.7735028266906738,0.172298401594162,negative,-0.7193040251731873
41,2017-01-19 00:38:00,"• The intrinsic value of K

This article first appeared on GuruFocus .",0.016064617782831192,0.0091302040964365,0.9748051762580872,neutral,0.0069344136863946915
42,2017-01-19 00:38:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
